Siemens Healthineers AG (FRA:SHL)
Market Cap | 54.46B |
Revenue (ttm) | 23.14B |
Net Income (ttm) | 2.09B |
Shares Out | n/a |
EPS (ttm) | 1.86 |
PE Ratio | 26.07 |
Forward PE | 19.01 |
Dividend | 0.95 (2.04%) |
Ex-Dividend Date | Feb 19, 2025 |
Volume | 609,208 |
Average Volume | 1,018,044 |
Open | 48.95 |
Previous Close | 48.79 |
Day's Range | 48.92 - 49.36 |
52-Week Range | 41.21 - 58.48 |
Beta | n/a |
RSI | 60.68 |
Earnings Date | May 7, 2025 |
About Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and... [Read more]
Financial Performance
In 2024, Siemens Healthineers AG's revenue was 22.36 billion, an increase of 3.15% compared to the previous year's 21.68 billion. Earnings were 1.94 billion, an increase of 28.69%.
Financial StatementsNews

EQS-DD: Siemens Healthineers AG: Marisol von Siemens, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 12.05.2025 / 11:17 CET/CEST The issuer is solely responsi...

EQS-DD: Siemens Healthineers AG: Hadrian Pausch von Siemens, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 12.05.2025 / 11:12 CET/CEST The issuer is solely responsi...

EQS-DD: Siemens Healthineers AG: Astrid Kristine Ploß, Program-based order to sell a portion of 73 Siemens Healthineers shares to cover tax and contribution obligations on share transfers in ...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 09.05.2025 / 14:56 CET/CEST The issuer is solely responsi...

EQS-DD: Siemens Healthineers AG: Astrid Kristine Ploß, Entitlement to transfer 73 Siemens Healthineers shares in connection with a Siemens Healthineers Share Program (transfer with value date ...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 09.05.2025 / 14:49 CET/CEST The issuer is solely responsi...

Healthineers: Reviewing Q2 And Updating My Targets (Rating Upgrade)
Siemens Healthineers reported strong Q2 '25 results, with 7% top-line growth and confirmed full-year outlook, despite challenges in China and tariffs. The company excels in imaging, holding a 37% mark...
Siemens Healthineers AG 2025 Q2 - Results - Earnings Call Presentation
Siemens Healthineers AG (SEMHF) Q2 2025 Earnings Call Transcript
Siemens Healthineers AG reports Q2 results
Siemens Healthineers Posts Profit, Revenue Rise; Adjusts Guidance on Tariff Uncertainty

Siemens Healthineers posts revenue beat, but lowers floor of profit outlook
German medical technology group Siemens Healthineers posted second quarter revenue slightly above market expectations on Wednesday, but brought down the lower end of its annual earnings forecast due t...

EQS-CMS: Siemens Healthineers AG: Release of a capital market information
EQS Post-admission Duties announcement: Siemens Healthineers AG / Disclosure pursuant to Art. 5 para. 1 lit. b), para. 3 of the Regulation (EU) No. 596/2014, as last amended by Regulation (EU) No. 202...

Cardiovascular Image Fusion Software Market Analysis Report, 2025-2035, Featuring Ziehm Imaging, TeraRecon, OsiriX, Materialise, Siemens Healthineers and More
Dublin, May 05, 2025 (GLOBE NEWSWIRE) -- The "Cardiovascular Image Fusion Software Market - A Global and Regional Analysis: Focus on Application, End User, and Country-Level Analysis - Analysis and Fo...

More Impact, Together: Varian and Siemens Healthineers Portfolios Highlight More Impact, Innovations and More Breakthroughs Throughout Cancer Care Journey at ESTRO 2025
PALO ALTO, Calif.--(BUSINESS WIRE)--Varian and Siemens Healthineers Portfolios Highlight More Impact, Innovations and More Breakthroughs Throughout Cancer Care Journey at ESTRO 2025.

EQS-AFR: Siemens Healthineers AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQS Preliminary announcement financial reports: Siemens Healthineers AG / Preliminary announcement on the disclosure of financial statements Siemens Healthineers AG: Preliminary announcement of the pu...

EQS-DD: Siemens Healthineers AG: Darleen Caron, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 22.04.2025 / 17:45 CET/CEST The issuer is solely responsi...

EQS-CMS: Siemens Healthineers AG: Release of a capital market information
EQS Post-admission Duties announcement: Siemens Healthineers AG / Disclosure pursuant to Art. 5 para. 1 lit. b), para. 3 of the Regulation (EU) No. 596/2014, as last amended by Regulation (EU) No. 202...

Siemens Healthineers and Vivolight Medical Collaborate to Launch DSA-OCT Integrated Multi-Modal Diagnostic and Treatment Platform, Ushering in a New Era of Intelligent Cath Labs
Shenzhen, China--(Newsfile Corp. - February 28, 2025) - Recently, the world's first DSA-OCT integrated multi-modal diagnostic and treatment platform (ARTIS icono floor), jointly developed by Siemens H...

Siemens sells 2% stake in Siemens Healthineers
German engineering company Siemens announced late on Wednesday it launched a sale of a 2% stake in healthcare subsidiary Siemens Healthineers.

Siemens Healthineers AG (SEMHF) Q1 2025 Earnings Call Transcript
Siemens Healthineers AG (OTCPK:SEMHF) Q1 2025 Earnings Conference Call February 6, 2025 2:30 AM ET Company Participants Marc Koebernick - Head, IR Bernd Montag - CEO Jochen Schmitz - CFO Conference Ca...

Siemens Healthineers says it would welcome stake reduction by Siemens
Siemens Healthineers' CEO said on Thursday that the medical-technology company had a "very positive" view on considerations by parent Siemens to reduce its stake.

Siemens Healthineers reports Q1 revenue slightly above consensus
German medical technology company Siemens Healthineers on Thursday reported first quarter revenue slightly above consensus, as its U.S. revenues increased by 16% while those from China declined 6% due...

Siemens Healthineers Digital Transformation Strategies, Innovation Programs and Technology Initiatives
The report provides insights into Siemens Healthineers' tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives. The report provides i...

InkSpace Imaging Receives FDA 510(k) Clearance for 1.5T 24-channel MR Coil for Siemens Healthineers
PLEASANTON, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- InkSpace Imaging, a leader in MRI coil innovation, today announced that the United States (US) Food and Drug Administration (FDA) has cleared InkS...

Siemens Healthineers Offers Imaging-Driven Upside For Patient Investors
Recent underperformance is likely due to below-expectations revenue, mixed margins, and lower fiscal 2025 guidance, despite strong imaging and radiation oncology performance. Imaging remains a major g...

Siemens Healthineers AG (SEMHF) Q4 2024 Earnings Call Transcript
Siemens Healthineers AG (OTCPK:SEMHF) Q4 2024 Results Conference Call November 6, 2024 2:00 AM ET Company Participants Marc Koebernick - Head-Investor Relations Bernd Montag - Chief Executive Officer ...